Scott & Selber Inc’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.31M | Sell |
10,397
-17
| -0.2% | -$2.24K | 0.28% | 66 |
|
|
2026
Q1 | $1.45M | Sell |
10,414
-34
| -0.3% | -$4.76K | 0.37% | 67 |
|
|
2025
Q4 | $1.28M | Sell |
10,448
-484
| -4% | -$58.8K | 0.32% | 71 |
|
|
2025
Q3 | $1.21M | Sell |
10,932
-135
| -1% | -$15.3K | 0.31% | 73 |
|
|
2025
Q2 | $1.23M | Buy |
11,067
+90
| +0.8% | +$9.58K | 0.34% | 72 |
|
|
2025
Q1 | $1.23M | Sell |
10,977
-2
| -0% | -$206 | 0.39% | 70 |
|
|
2024
Q4 | $1.01M | Buy |
10,979
+7
| +0.1% | +$630 | 0.31% | 73 |
|
|
2024
Q3 | $920K | Sell |
10,972
-86
| -0.8% | -$6.56K | 0.29% | 76 |
|
|
2024
Q2 | $759K | Buy |
11,058
+81
| +0.7% | +$5.41K | 0.24% | 78 |
|
|
2024
Q1 | $804K | Sell |
10,977
-71
| -0.6% | -$5.46K | 0.27% | 79 |
|
|
2023
Q4 | $895K | Sell |
11,048
-27
| -0.2% | -$2.1K | 0.34% | 80 |
|
|
2023
Q3 | $830K | Sell |
11,075
-22
| -0.2% | -$1.69K | 0.34% | 83 |
|
|
2023
Q2 | $855K | Sell |
11,097
-28
| -0.3% | -$2.23K | 0.33% | 84 |
|
|
2023
Q1 | $923K | Buy |
11,125
+38
| +0.3% | +$3.15K | 0.39% | 82 |
|
|
2022
Q4 | $952K | Sell |
11,087
-12
| -0.1% | -$950 | 0.43% | 81 |
|
|
2022
Q3 | $685K | Buy |
11,099
+48
| +0.4% | +$3.03K | 0.33% | 87 |
|
|
2022
Q2 | $683K | Sell |
11,051
-740
| -6% | -$45.8K | 0.31% | 89 |
|
|
2022
Q1 | $701K | Sell |
11,791
-162
| -1% | -$10.4K | 0.27% | 90 |
|
|
2021
Q4 | $868K | Buy |
+11,953
| New | +$823K | 0.31% | 88 |
|
|
2016
Q2 | – | Sell |
-24,272
| Closed | -$2.23M | – | 66 |
|
|
2016
Q1 | $2.23M | Buy |
24,272
+91
| +0.4% | +$8.21K | 1.49% | 36 |
|
|
2015
Q4 | $2.45M | Buy |
24,181
+188
| +0.8% | +$19.6K | 1.59% | 31 |
|
|
2015
Q3 | $2.36M | Buy |
23,993
+42
| +0.2% | +$4.67K | 1.74% | 29 |
|
|
2015
Q2 | $2.8M | Sell |
23,951
-446
| -2% | -$48.7K | 1.93% | 23 |
|
|
2015
Q1 | $2.39M | Sell |
24,397
-1,368
| -5% | -$139K | 1.62% | 32 |
|
|
2014
Q4 | $2.43M | Sell |
25,765
-121
| -0.5% | -$12.5K | 1.63% | 35 |
|
|
2014
Q3 | $2.76M | Sell |
25,886
-18,631
| -42% | -$1.82M | 1.92% | 11 |
|
|
2014
Q2 | $3.69M | Sell |
44,517
-7
| -0% | -$545 | 2.45% | 4 |
|
|
2014
Q1 | $3.15M | Sell |
44,524
-132
| -0.3% | -$10.4K | 2.21% | 9 |
|
|
2013
Q4 | $3.35M | Buy |
44,656
+32
| +0.1% | +$2.23K | 2.45% | 5 |
|
|
2013
Q3 | $2.81M | Hold |
44,624
| – | – | 2.26% | 5 |
|
|
2013
Q2 | $2.29M | Buy |
+44,624
| New | +$2.33M | 2% | 16 |
|
Other funds holding GILD
Scott & Selber Inc's GILD Position: Q2 2026 in Review
Scott & Selber Inc reduced its Gilead Sciences (GILD) stake by 0.16% in Q2 2026, selling an estimated $2.24K and leaving 10,397 shares worth $1.31M. The position accounts for 0.28% of the portfolio, ranked #66.
Scott & Selber Inc first reported a position in GILD in Q2 2013 and has held it in 31 quarters since. The position peaked at $3.69M in Q2 2014. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Scott & Selber Inc held 10,397 shares of Gilead Sciences worth $1.31M as of Q2 2026.
- Scott & Selber Inc sold 17 Gilead Sciences shares in Q2 2026, an estimated $2.24K.
- Gilead Sciences made up 0.28% of Scott & Selber Inc's portfolio in Q2 2026, its #66 holding.
- Scott & Selber Inc first reported a position in Gilead Sciences in Q2 2013 and has held it in 31 quarters since.
- Scott & Selber Inc's Gilead Sciences position peaked at $3.69M in Q2 2014.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Scott & Selber Inc's 13F filing for Q2 2026, filed 8 Jul 2026.